` NMTC (Neuroone Medical Technologies Corp) vs S&P 500 Comparison - Alpha Spread

NMTC
vs
S&P 500

Over the past 12 months, NMTC has underperformed S&P 500, delivering a return of -1% compared to the S&P 500's +14% growth.

Stocks Performance
NMTC vs S&P 500

Loading
NMTC
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NMTC vs S&P 500

Performance Gap Between NMTC and GSPC
HIDDEN
Show

Performance By Year
NMTC vs S&P 500

Loading
NMTC
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Neuroone Medical Technologies Corp vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Neuroone Medical Technologies Corp
Glance View

Market Cap
36.6m USD
Industry
Health Care

NeuroOne Medical Technologies Corp. operates as a medical technology company. The company is headquartered in Eden Prairie, Minnesota and currently employs 11 full-time employees. The company went IPO on 2012-11-09. The firm is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. The company also investigating the applications of its technology associated with artificial intelligence. The company develops its cortical, sheet and depth electrode technology to provides solutions for diagnosis through cEEG recording and sEEG recording and treatment through brain stimulation and ablation. Its commercialized product, Evo sEEG electrode technology records, monitors and stimulates electrical signals at the subsurface level of the brain.

NMTC Intrinsic Value
HIDDEN
Show
Back to Top